Astrana Health Narrows FY2026 Revenue Guidance to $3.9 Billion-$4 Billion

PUBT · 3d ago
Astrana Health Narrows FY2026 Revenue Guidance to $3.9 Billion-$4 Billion
  • Astrana Health forecasts fiscal 2026 revenue of $3.9 billion–$4 billion, implying 24.1% growth at the midpoint.
  • Adjusted EBITDA guidance stands at $261 million–$274 million, representing 30.2% midpoint growth.
  • Free cash flow is projected at $107.5 million–$130 million, implying 13.6% growth at the midpoint.
  • Third-quarter revenue reached $1.02 billion; adjusted EBITDA totaled $77.2 million.
  • Year-to-date consolidated medical cost trends are tracking below the full-year assumption of approximately 5.2%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Astrana Health Inc. published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.